Published Time：

3 On the morning of August 8th, Nanshan District held a commemorative event for the 111th anniversary of International Women's Day, themed "Learning Party History, Singing the Party's Grace, Following the Party's Lead - Hundreds of Women Offering Gifts to Celebrate the Party's Centenary," at the Nanshan District Women and Children's Activity Center. The event shared stories of women's achievements, paid tribute to heroic women, and called on women of the new era to continue writing a new chapter in women's undertakings, as a tribute to the 100th anniversary of the founding of the Communist Party of China.

Nanshan District Party Secretary Zeng Pai, Shenzhen Women's Federation Chairwoman Ma Hong, Nanshan District Deputy Party Secretary and District Head Huang Xiangyue, Director of the District People's Congress Standing Committee Rao Honglei, Chairman of the District Political Consultative Conference Chen Jun, and Deputy Party Secretary Yin Shubing, among other leaders, attended the event.

In the selection and commendation work of the March 8th Red Flag Bearers and March 8th Red Flag Collectives carried out by the Shenzhen Women's Federation, the female employees of Jiankangyuan Pharmaceutical Group have shown their strength and achieved frequent good news. After several stages including recommendation, review, announcement, and evaluation, Jiankangyuan Pharmaceutical Group stood out among many candidate collectives and won the title of "Shenzhen March 8th Red Flag Collective".

Joincare Pharmaceutical Group Industry Co., Ltd. was founded in 1992 and listed on the Shanghai Stock Exchange in June 2001. It includes two listed companies, Jiankangyuan and Lizhu, with nearly 13,000 employees. After years of operation and development, it has become an innovative research-oriented pharmaceutical group, integrating the research, development, production, sales, and service of pharmaceutical and health products. Its product range covers more than 500 varieties in multiple fields, including chemical preparations, chemical raw materials and intermediates, diagnostic reagents, traditional Chinese medicine preparations, and health foods. It has currently established four major high-barrier complex preparation R&D platforms. Among them, the respiratory preparation R&D platform has taken the lead in breaking through the international market monopoly and has become a leading domestic inhaler preparation manufacturer.

"Women's achievements demonstrate their elegance; dedication to their professions composes new melodies." Jiankangyuan Group headquarters has a total of 356 staff members, of whom 60.39% are female employees. In various positions within Jiankangyuan Group, the presence of women is everywhere. With their unique gentleness, kindness, enthusiasm, and meticulousness, they learn and practice the Scientific Outlook on Development, uphold the spirit of "self-respect, self-confidence, self-reliance, and self-improvement," and have repeatedly created outstanding achievements for the group, demonstrating the professional style of modern women.

A large number of female employees, through their own abilities and strength, have entered leadership positions, management positions, and the ranks of mid-to-senior technical personnel, reflecting their positive contributions.

Those who strive without waiting for orders advance; those who practice responsibility forge ahead.

The General Secretary pointed out: "Spirit is the soul on which a nation depends for its long-term survival. Only when a nation reaches a certain height spiritually can it stand firm and forge ahead in the torrent of history." Things have their sweetness and bitterness; those who taste them know. Paths have their ease and danger; those who walk them know. On the road to practicing corporate social responsibility, Jiankangyuan Group has always adhered to a spirit of relentless progress, leaving a clear mark of the spirit of the ox, the pioneering ox, and the old ox, cherishing the childlike feelings of shouldering social responsibility, and striving to promote universal health coverage together with its peers in the pharmaceutical industry.

Faced with the sudden COVID-19 epidemic, all employees of Jiankangyuan Group, under the leadership of Chairman Zhu Baoguo, fought on all fronts, fully demonstrating the "fighting" spirit of a listed pharmaceutical company. To help achieve the great goal of national poverty alleviation, turning the vision of "everyone, regardless of poverty or wealth, has the right to enjoy a healthy old age" into reality, Jiankangyuan Group launched a chronic disease poverty alleviation project, actively expanding the "progress" of listed pharmaceutical companies. Among them, there are many female employees.

2020 In 2020, during the fight against the COVID-19 epidemic, female leaders of Jiankangyuan mobilized all the company's resources and manpower to support the fight against the epidemic. During this period, the group and its subsidiary Lizhu Pharmaceutical donated a total value of over 22 million yuan, including 4 million yuan in cash to support the Zhong Nanshan Foundation, 6 million yuan in cash to support the construction of Wuhan's epidemic defense base, and medical supplies worth 12 million yuan mainly used for the treatment of severe infections and prevention and detection caused by the novel coronavirus pneumonia.

2018 In 2020, actively responding to the national call and combining the company's own advantages, Jiankangyuan launched a precision poverty alleviation project. By December 2020, the project had covered 5 provinces, 10 counties, and 1 township, donating chronic disease medicines with a total value of 11 million yuan, and had helped approximately 4,200 registered poor households. During the implementation of the chronic disease poverty alleviation project, it received attention from all sectors of society and won the "Top Ten Caring Enterprises" award in 2020 from the Shenzhen Municipal Care Office; it won the "Excellent Case Award for Poverty Prevention" at the third China Excellent Poverty Alleviation Case Report Conference, guided by the State Council Poverty Alleviation Office and People's Daily, and hosted by People's Daily Online and China Poverty Alleviation magazine; and the series of documentaries "Chronic Disease Poverty Alleviation: Old Age Security" won the "Excellent Work Award for Shenzhen Corporate Culture Micro-videos".

Excellence in heart, innovation in strength, determination in action, contributing women's strength to the construction of the "dual zones".

Jiankangyuan Group deeply implements the Scientific Outlook on Development, upholds the R&D aspiration of "carefully making good medicines and new medicines," and works together in unity, loves its post and profession, makes selfless contributions, and is determined to innovate. In recent years, it has achieved outstanding results in theoretical innovation, management innovation, and technological innovation.

At the same time, Jiankangyuan pays attention to the organic combination of social benefits, economic benefits, and talent benefits, playing a leading and exemplary role in the same industry, and many women have emerged who have created outstanding achievements, contributing women's strength to the construction of the Guangdong-Hong Kong-Macao Greater Bay Area and Shenzhen Pilot Demonstration Zone "dual zones" and the implementation of Shenzhen's comprehensive reform pilot program, celebrating the 100th anniversary of the founding of the Party with practical actions and outstanding achievements.

In the group's intellectual property management work, female employees and leaders have also been aggressive and achieved outstanding results. Through joint efforts, by the end of 2020, Jiankangyuan Group:

Had a total of 826 patent applications, including 543 domestic invention patents;

Had a total of 558 authorized patents, including 320 domestic invention patents;

Had 71 international patent applications, of which 48 were authorized;

Submitted 18 PCT international applications, ranking among the top in the pharmaceutical industry;

The key product Meropenem patent "Preparation method of Meropenem" (ZL200610083362.7) of the group's subsidiary Haibin Pharmaceutical won the 2010 Shenzhen Patent Award and the 16th China Patent Excellence Award;

The patent "A traditional Chinese medicine preparation for treating women's menopausal syndrome" (ZL01139059.X) of the group's subsidiary Tai Tai Pharmaceutical won the 20th China Patent Excellence Award.

In addition, Jiankangyuan has successively won the "Shenzhen Intellectual Property Advantage Enterprise," "Guangdong Intellectual Property Advantage Enterprise," "Guangdong Intellectual Property Demonstration Enterprise," "Guangdong Key Intellectual Property Protection Enterprise," "National Intellectual Property Advantage Enterprise," and "National Intellectual Property Demonstration Enterprise" awards.

People-oriented, working hand in hand.

For many years, while focusing on its own business, HealthGen Group has been committed to growing with its employees, providing every employee with opportunities for sustainable development. The achievements and contributions of female employees in their work, showcasing their talents and realizing their self-worth, are inseparable from the Group's emphasis on protecting the rights and interests of female employees.

Through compliant policies and systems, a diversified training system, and a comprehensive salary and welfare mechanism, HealthGen provides a broad stage for female employees to showcase their talents while continuously improving the work environment. For example, establishing a lactation room for breastfeeding female employees and organizing outdoor activities and gatherings for all female employees every Women's Day. HealthGen has always been making positive efforts to provide employees with highly competitive salaries and benefits and diversified development platforms in the industry.

“Spring flowers are luxuriant, delicate and fragrant.” The development of the times has liberated women, allowing them to demonstrate their outstanding abilities in all aspects of society. In today's rapidly developing technology, women will play an even more important role in more fields.

In the future, HealthGen Group will continue to care about the work of female employees, pay attention to cultivating female cadres, and allow female employees to play a greater role in their work. The heroic women of HealthGen will also continue to work at their posts, strive for excellence, innovate, and strive for outstanding achievements. Together with the Group, they will undertake more social responsibilities, practice the corporate spirit of the Bay Area enterprises, and influence more people and social forces to participate in the construction and great rejuvenation of the motherland.